Tag: PRES

FDA Approves Papzimeos for Adults With Recurrent Respiratory Papillomatosis

Papzimeos is the first and only FDA-approved therapy for the treatment ...

READ MORE

Dalbavancin Noninferior to Standard Therapy for Complicated S. Aureus Bacteremia

Dalbavancin not superior to standard therapy, but met the noninferiority criterion ...

READ MORE